Stopped: Difficulty of inclusion
To assess if the non use of heparin sodium during balloon aortic valvuloplasty reduces serious complications due to the procedure, by decreasing the rate of vascular and hemorrhagic complications without increasing the rate of ischeamic events.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of serious complication : vascular, hemorrhagic or ischaemic complication
Timeframe: Up to10 days after the valvuloplasty (D1-D10 after the intervention)